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ABSTRACT Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen
with distinct acute and chronic virulence phenotypes. Whereas acute virulence is
typically associated with expression of a type III secretion system (T3SS), chronic vir-
ulence is characterized by biofilm formation. Many of the phenotypes associated
with acute and chronic virulence are inversely regulated by RsmA and RsmF. RsmA
and RsmF are both members of the CsrA family of RNA-binding proteins and regu-
late protein synthesis at the posttranscriptional level. RsmA activity is controlled by
two small noncoding regulatory RNAs (RsmY and RsmZ). Bioinformatic analyses sug-
gest that RsmY and RsmZ each have 3 or 4 putative RsmA binding sites. Each pre-
dicted binding site contains a GGA sequence presented in the loop portion of a
stem-loop structure. RsmY and RsmZ regulate RsmA, and possibly RsmF, by seques-
tering these proteins from target mRNAs. In this study, we used selective 2=-hydroxyl
acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) chem-
istry to determine the secondary structures of RsmY and RsmZ and functional assays
to characterize the contribution of each GGA site to RsmY/RsmZ activity. Our data
indicate that RsmA has two preferential binding sites on RsmY and RsmZ, while
RsmF has one preferential binding site on RsmY and two sites on RsmZ. Despite
RsmF and RsmA sharing a common consensus site, RsmF binding properties are
more restrictive than those of RsmA.
IMPORTANCE CsrA homologs are present in many bacteria. The opportunistic
pathogen Pseudomonas aeruginosa uses RsmA and RsmF to inversely regulate fac-
tors associated with acute and chronic virulence phenotypes. RsmA has an affinity
for RsmY and RsmZ higher than that of RsmF. The goal of this study was to under-
stand the differential binding properties of RsmA and RsmF by using the RsmY and
RsmZ regulatory small RNAs (sRNAs) as a model. Mutagenesis of the predicted
RsmA/RsmF binding sites on RsmY and RsmZ revealed similarities in the sites re-
quired to control RsmA and RsmF activity in vivo. Whereas binding by RsmA was rel-
atively tolerant of binding site mutations, RsmF was sensitive to disruption to all but
two of the sites, further demonstrating that the requirements for RsmF binding ac-
tivity in vivo and in vitro are more stringent than those for RsmA.
KEYWORDS Pseudomonas aeruginosa, RsmA, RsmF, CsrA, RsmY, RsmZ, sRNA, type III
secretion
The survival of opportunistic bacterial pathogens is dependent upon the ability tosense and adapt to changing conditions within the host and environment. The
most common adaptive response is to alter gene expression and/or protein synthesis
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Although RsmA and RsmF share several binding targets, including RsmY and RsmZ,
patterns. Large-scale alterations to the transcriptome/proteome often involve global 
regulators (1). Global regulation can occur at the transcriptional, posttranscriptional, 
and/or posttranslational level. A well-studied posttranscriptional regulator is Escherichia 
coli CsrA (carbon storage regulator), which plays a central role in carbon metabolism (2, 
3). CsrA is a homodimeric RNA-binding protein that can have both negative and 
positive effects on protein synthesis (4). The general mechanism of repression by CsrA 
is to physically interfere with translation initiation by binding to a site that overlaps the 
ribosome binding site on target mRNAs (5–7). The CsrA consensus binding site consists 
of a core GGA sequence located in the single-stranded region of an RNA stem-loop 
structure, with the highest-affinity sites possessing pentaloop structures (8). Since each 
CsrA dimer contains two RNA-binding domains, full regulatory control often involves 
binding to an additional site on the target RNA (9). Although CsrA usually inhibits 
translation, examples of positive regulation have been described, the mechanisms of 
which include protection of the target mRNA from degradation and an increased rate 
of translation initiation (6, 10).
CsrA orthologs are found in a wide range of bacteria (7). The opportunistic pathogen 
Pseudomonas aeruginosa has two CsrA orthologs: RsmA (regulator of secondary me-
tabolites) and RsmF (described below). RsmA was first shown to play a role in control-
ling the production of virulence factors, including elastase, LasA protease, hydrogen 
cyanide, and pyocyanin (11). The RsmA regulon is now known to consist of 500 target 
genes (12, 13). Notably, RsmA inhibits the synthesis of several gene products thought 
to play a role in persistent colonization of the airways in cystic fibrosis patients. Those 
products include components of a type VI secretion system (T6SS) and factors that 
promote biofilm formation (14, 15). Conversely, RsmA positively regulates genes asso-
ciated with acute infection, including the type III secretion system (T3SS) and type IV pili 
(12, 16). RsmA activity is regulated by two small noncoding RNAs, designated RsmY and 
RsmZ. RsmY and RsmZ possess multiple RsmA binding sites that function to sequester 
RsmA from target mRNAs (17). Expression of rsmY and rsmZ is regulated at the 
transcriptional level by the GacS/A two-component system and two orphan sensor 
kinases, LadS and RetS (18, 19). The environmental signals resulting in altered RsmY and 
RsmZ synthesis are poorly understood. Nevertheless, sequestration of RsmA by RsmY/
RsmZ results in reduced RsmA availability and preferential expression of virulence 
factors associated with chronic colonization. Conversely, high RsmA availability favors 
expression of factors associated with acute virulence (20). Because of this inverse 
relationship, RsmA is thought to play a pivotal role in controlling the transition from 
acute to chronic colonization (12, 13, 21).
Several of the pseudomonads, including P. fluorescens, P. protegens, P. putida, and P. 
aeruginosa, have multiple CsrA proteins (22–25). In P. fluorescens, RsmA and RsmE are 
structurally similar and appear to be redundant in function (23). P. putida RsmA, RsmE, 
and RsmI are also homologous, but distinct roles for each have been described (26). In 
contrast, P. aeruginosa RsmA and RsmF (also called RsmN) are structurally distinct and 
share some, but not all, regulatory targets (24, 25, 27). Both RsmA and RsmF are 
homodimers, with similar RNA-binding surfaces composed of five -sheets, but they 
differ in how the RNA-binding surface is formed. The RNA-binding surface in RsmF is 
formed by 1, 3, and 4 from one polypeptide and 2 and 5 from the second 
polypeptide (24, 25). In other CsrA proteins, including RsmA, the RNA-binding surface 
consists of 2, 3, and 4 from one polypeptide and 1 and 5 from the second 
polypeptide (28–30). Despite the significant difference in structure, both proteins 
possess a similarly positioned arginine residue (R44 in RsmA and R62 in RsmF) that is 
critical for RNA-binding activity (24, 25, 30). The RNA-binding activity of both proteins 
is also dependent on the core GGA motif, since RNA targets carrying CCU substituted 
for GGA are poorly bound (24). Finally, data from systematic evolution of ligands by 
exponential enrichment experiments (SELEX) found that RsmA and RsmF share a 
consensus binding sequence (CAnGGAyG), with 100% conservation of the core GGA 
sequence (underlined) (27).
there are significant differences in the interactions with those targets. Data from 
electrophoretic mobility shift assays (EMSAs) suggest that three RsmA dimers bind to 
RsmZ with affinities in the low nanomolar range (24). RsmA binding to RsmY is also in 
the low nanomolar range. In contrast, only one RsmF dimer appears to bind to RsmZ, 
and the affinities for both RsmY and RsmZ are reduced nearly 50-fold relative to those 
of RsmA (24). In this study, we report the preferences of RsmA and RsmF for the 
predicted binding sites in RsmY and RsmZ as a means to better understand the basis 
for differential binding of target RNAs.
RESULTS
Structural analyses of RsmY and RsmZ. We previously reported that RsmF binds 
to the RsmY and RsmZ RNAs with significantly lower affinities than those of RsmA (24). 
To gain further insight into the differential binding properties of RsmA and RsmF, we 
sought to characterize RsmA/RsmF binding sites on RsmY and RsmZ. The consensus 
binding sites determined by SELEX for both RsmA and RsmF contain a critical GGA 
sequence (CAnGGAyG) that is presented in the loop portion of a stem-loop structure (4, 
27). RsmY and RsmZ each contain seven GGA sequences, designated GGA1 to GGA7 
starting from the 5= end of the RNAs (Fig. 1A and 2A). Comparison of each GGA 
sequence to the full RsmA/RsmF consensus binding site (CAnGGAyG) shows matches 
that range from 4 to 7 positions (see Fig. S1 in the supplemental material). Mfold predic-
tions suggest that three of the RsmY GGA sequences (sites 2, 5, and 7) and three of the 
RsmZ GGA sequences (sites 2, 5, and 6) are presented in the loop portion of stem-loop 
structures (Fig. 1A and 2A) (31). In some instances, CsrA proteins also bind unpaired GGA 
sequences that are not presented in stem-loop structures. The Mfold predictions show that 
RsmY GGA sequences 1, 3, and 4 and RsmZ GGA sites 1, 4, and 7 are unpaired, making each 
potentially available for RsmA/RsmF interactions (Fig. 1A and 2A).
To experimentally verify the RsmY and RsmZ secondary structure, we performed 
selective 2=-hydroxyl acylation analyzed by primer extension and mutational pro-
filing (SHAPE-MaP) (32–34). SHAPE-MaP determines the reactivity of the 1-methyl-7-
nitroisatoic anhydride (1M7) chemical probe with each nucleotide in an RNA. Higher 
reactivity indicates more flexibility, which is generally indicative of unpaired nucleo-
tides. The free energy of RNA folding incorporated into the SHAPE-MaP data predicts 
minimum free energy structures that are different from the Mfold predictions. Both 
Mfold and SHAPE-MaP are consistent in predicting that RsmY GGA sequences 2 and 5 
are presented in the loop portion of stem-loop structures and that GGA sequences 1, 
3, and 4 are unpaired (Fig. 1A and B). The only major discrepancy between the Mfold 
and SHAPE predictions for RsmY is whether GGA site 7 is presented in the loop portion 
of a stem-loop structure, as predicted by Mfold, or remains base paired and inaccessible 
for RsmA/RsmF binding, as predicted by SHAPE-MaP. An in vivo cleavage structure for 
P. fluorescens RsmY found that GGA sites 2 and 5 are presented in the loop portion of 
stem-loop structures (Fig. 1C) (35). Alignment of RsmY sequences from both organisms 
shows strong conservation of the nucleotides that comprise the stem and loop regions 
for GGA sites 2 and 5 (Fig. 1D). Consistent with this, the P. aeruginosa RsmY SHAPE-MaP 
and P. fluorescens RsmY structures for GGA sites 2 and 5 bear a striking resemblance to 
one another. These combined data suggest that P. aeruginosa RsmY GGA site 7 may not 
be accessible for RsmA/RsmF.
The predicted SHAPE-MaP structure for RsmZ has three GGA sequences presented 
in stem-loop structures (sites 2, 5, and 6) and three GGA sequences that are unpaired 
(sites 1, 4, and 7) (Fig. 2B). The Mfold and SHAPE-MaP data are very similar and differ 
only in the terminator region (Fig. 2A and B). A recent nuclear magnetic resonance 
(NMR) structure for P. fluorescens RsmZ found that GGA sites 1, 2, 5, and 6 are presented 
in the loop portion of stem-loop structures (36) (Fig. 1C). Alignment of the RsmZ 
sequences from both organisms shows strong conservation of the nucleotides that 
comprise the stem and loop regions for GGA sites 5 and 6, weak conservation around 
site 2, and minimal conservation around site 1 (Fig. 1D). Consistent with this, the P. 
aeruginosa RsmZ SHAPE-MaP and P. fluorescens RsmZ NMR structures for GGA sites 2,
FIG 1 Predicted and determined structures of RsmY. (A) Predicted P. aeruginosa (Pa) RsmY secondary structure determined by Mfold 
modeling. (B) SHAPE-MaP structure for P. aeruginosa RsmY. (C) P. fluorescens (Pf) RsmY secondary structure predicted by Mfold. (D) 
Alignment of P. aeruginosa and P. fluorescens rsmY sequences. GGA motifs are numbered 1 to 7 and highlighted in red. Stem 
structures are highlighted in blue, and terminator regions are shown in brown.
5, and 6 resemble one another. These combined data suggest that P. aeruginosa RsmZ
GGA site 1 may not be presented in the context of a stem-loop structure.
Roles of RsmY and RsmZ GGA sequences in vivo. To determine which GGA sites
are important for RsmY and RsmZ regulatory activity, each of the GGA sequences within
FIG 2 Predicted and determined structures of RsmZ. (A) Predicted Mfold structure for P. aeruginosa RsmZ. (B) 
SHAPE-MaP structure for P. aeruginosa RsmZ. (C) P. fluorescens RsmZ NMR structure. (D) Alignment of P. 
aeruginosa and P. fluorescens rsmZ sequences. GGA motifs are numbered 1 to 7 and highlighted in red. Stem 
structures are highlighted in blue, and terminator regions are shown in brown.
stem-loop structures predicted by either Mfold or SHAPE-MaP was changed to CCU. 
Select double, triple, and quadruple substitution mutants were also constructed as 
described below. Each of the RNAs was expressed from a plasmid under the control of
an arabinose-inducible promoter and tested for regulatory activity in vivo. Regulatory
activity was measured using a previously described PtssA1=-=lacZ translational reporter
(24) integrated at the chromosomal CTX phage attachment site of P. aeruginosa strain
PA103. The tssA1 operon encodes components of T6SS-1, and tssA1 translation is
repressed by the direct binding of RsmA to the tssA1 mRNA leader region, as seen for
wild-type cells and mutants lacking rsmF, rsmYZ, or rsmFYZ (Fig. 3) (12, 24). Conversely,
reporter activity is derepressed when rsmA is deleted from the wild-type and rsmYZ
backgrounds. Although deletion of rsmF alone has no effect on PtssA1=-=lacZ reporter
activity, mutants lacking both rsmA and rsmF (i.e., rsmAF and rsmAFYZ mutants) have
much higher levels of reporter activity than those of the single rsmA mutant and the
rsmAYZ mutant (Fig. 3).
To specifically examine the regulation of RsmA and RsmF activity, the following
experiments were performed in the rsmFYZ and rsmAYZ mutant backgrounds, respec-
tively. Whereas rsmFYZ and rsmAYZ strains carrying a vector control (pJN105) have low
levels of PtssA1=-=lacZ reporter activity, plasmid-expressed RsmY or RsmZ sequester RsmA
or RsmF, resulting in significant activation of reporter activity (Fig. 4A to D). Examination
FIG 3 Control of tssA1=-=lacZ translational reporter activity by the RsmAFYZ system. The indicated
mutants carrying the tssA1=-=lacZ translational reporter were cultured to mid-exponential phase and
assayed for -galactosidase activity by use of CPRG as a substrate.
FIG 4 Regulation of RsmA and RsmF activities by mutant RsmY and RsmZ regulatory RNAs. The ΔrsmFYZ 
(A and C) and ΔrsmAYZ (B and D) mutants bearing the tssA1=-=lacZ translational reporter were trans-
formed with the indicated RsmY (A and B) or RsmZ (C and D) expression plasmids. Transformants were 
cultured to mid-exponential phase in the presence of 0.1% arabinose to induce expression of the 
respective RNAs and then assayed for -galactosidase activity. Reported values represent the averages 
for at least three experiments, with standard errors indicated by error bars. The indicated statistically 
significant differences (*, P  0.05) are relative to strains expressing either native RsmY (A and B) or RsmZ 
(C and D), normalized to 100% activity.
of the RsmY GGA mutant panel expressed in the rsmFYZ background revealed that the 
site 2 and site 5 GGA mutants had significantly reduced PtssA1=-=lacZ reporter activity, 
while the site 7 GGA mutant had activity levels similar to those of wild-type RsmY (Fig. 4A). 
The GGA27 and GGA57 double mutants (with mutations of GGA sites 2 and 7 and GGA 
sites 5 and 7, respectively) had activities similar to those of the single GGA2 and GGA5 
mutants, further demonstrating that GGA7 is dispensable for RsmY activity. The GGA25 
double mutant and GGA257 triple mutant also had significant reductions in activity 
compared to the activity of wild-type RsmY, indicating that sites 2 and 5 are necessary 
for maximal sequestration of RsmA.
Using the rsmAYZ background to examine RsmF activity, the RsmY GGA site 5 
mutant had a significant defect in regulation of RsmF activity, the site 2 mutant had a 
modest but still significant defect, and the site 7 mutant had activity levels to similar to 
those of native RsmY (Fig. 4B). As observed above for RsmA, the GGA27 and GGA57 
double mutants had activities similar to those of the single GGA2 and GGA5 mutants, 
indicating that site 7 does not significantly contribute to regulation of RsmA or RsmF 
activity (Fig. 4B). These combined findings suggest that GGA sites 2 and 5 are the 
primary sites on RsmY for RsmF binding.
Using the same strategy, we next examined which GGA sites in RsmZ are important 
for controlling RsmA and RsmF activity by creating single, double, triple, and quadruple 
mutants. Examination of the RsmZ mutant panel in the rsmFYZ background revealed 
that the site 1, 2, and 6 mutants had reduced activity relative to that of native RsmZ and 
that sites 1, 2, and 6 are thus required for maximal activity (Fig. 4C). The site 1 mutant 
in particular was completely devoid of activity and had the strongest phenotype of all 
of the single mutants examined. The site 5 GGA mutant had activity levels similar to 
that of native RsmZ. A role for GGA site 5 cannot be excluded, though, because the 
activity of the GGA56 double mutant was significantly lower than that of the site 6 GGA 
mutant alone.
We saw a similar trend for RsmF in that RsmZ sites 1, 2, and 6 were required for 
maximal activity (Fig. 4D). The phenotype of the site 1 mutant, however, was not nearly 
as pronounced in the rsmAYZ mutant. Similar to our findings for RsmA, RsmZ site 5 was 
also largely dispensable for regulation of RsmF activity.
Decreased stability of mutant RsmY and RsmZ RNAs does not account for 
defects in regulatory activity in vivo. The simplest interpretation of the above data 
is that the decreased activity of the mutant RsmY and RsmZ RNAs correlates with a 
reduced capacity to bind and sequester RsmA/F. An alternative explanation is that the 
GGA-to-CCU substitutions reduced the stability of the RNAs under steady-state condi-
tions. Mfold predictions for the mutant RNAs, however, indicate that the single CCU 
substitutions did not alter the secondary structures of the RNAs. The CCU substitutions, 
however, might create or destroy RNase cleavage sites. To directly examine RsmY and 
RsmZ stability, we performed quantitative reverse transcription-PCR (qRT-PCR). RNA 
samples were isolated from each RsmY- or RsmZ-expressing strain (grown to mid-
exponential phase). The expression level of each RNA was normalized to that of rimM, 
a housekeeping gene encoding a ribosomal protein (37), and expression levels are 
reported relative to those of wild-type RsmY or RsmZ. Only two of the mutant RNAs, 
RsmY GGA57 and RsmZ GGA1256, had 2-fold reductions in expression, though these 
were not significant based on analysis of variance (ANOVA) (Fig. 5A and B). The lower 
steady-state level of RsmZ GGA1256 may have contributed to the significant loss of 
activity observed for RsmA (Fig. 4C). The remaining RsmY and RsmZ mutants had 
expression levels similar to or greater than those of wild-type RsmY and RsmZ, with 
RsmY GGA27, RsmZ GGA6, and RsmZ GGA256 levels being increased 3-fold, for 
reasons that are unclear (Fig. 5A and B). These findings indicate that the reduced 
stability of the single GGA mutant RsmY and RsmZ RNAs did not significantly contribute 
to the observed changes in regulation of RsmA and RsmF activity.
Effects of RsmY GGA substitutions on RsmA and RsmF binding in vitro. To 
further investigate the interactions between RsmA/RsmF and RsmY/RsmZ, we mea-
FIG 5 RsmY and RsmZ steady-state expression levels. Cells were cultured to mid-exponential phase in 
the presence of 0.1% arabinose to induce expression of the respective RNAs, at which time samples were 
harvested for RNA preparation and quantitation by qRT-PCR. Levels of mutant RsmY (A) or RsmZ (B) RNAs 
relative to that of native RsmY (A) or RsmZ (B) (normalized to 1.0) are shown. Each RNA sample was 
normalized to rimM. The reported values represent the averages for at least three experiments, with 
standard errors indicated by error bars. The indicated statistically significant differences (*, P  0.05) are 
relative to strains expressing either native RsmY (A) or RsmZ (B).
sured in vitro binding by using EMSAs. Full-length RsmY and RsmZ and mutant RNAs 
were synthesized in vitro, radiolabeled at the 5= end, and incubated with purified
RsmAHis or RsmFHis prior to electrophoresis in nondenaturing gels. As previously 
reported (24), RsmAHis binds RsmY with a high affinity, resulting in the formation of 
three distinct complexes (Fig. 6A). These complexes likely reflect binding by multiple
RsmAHis dimers and/or RsmAHis interactions with different sites on RsmY that alter 
migration of the complexes. Disruption of RsmY site GGA2, GGA5, or both (GGA25) had
no significant effect on RsmAHis affinity or complex formation (Fig. 6B to D). The GGA57
double mutant also had no effect on RsmA affinity, but only two distinct complexes 
were observed (Fig. S2A). Curiously, disruption of the GGA7 and GGA27 sites resulted
in an 10-fold higher affinity of RsmAHis (Fig. S1B and C). Although three distinct 
complexes were seen with the GGA7 mutant, only two complexes were evident with
the GGA27 mutant. A significant reduction in RsmAHis affinity was observed with the 
GGA257 triple mutant, but complex formation was still observed at higher RsmAHis 
concentrations (Fig. S2D). To determine whether lower-affinity interactions at subop-
timal GGA sites account for residual binding to the GGA257 mutant, mutations were 
introduced into GGA sites 1, 3, and 4. Whereas RsmA still bound the GGA134 mutant 
with high affinity (Fig. 6E), binding to the GGA123457 mutant was entirely ablated (Fig. 
6F). These findings suggest that GGA sites 2, 5, and 7 are the primary determinants for
RsmAHis-RsmY complex formation in vitro and that sites 1, 3, and 4 make minor 
contributions to binding.
The binding experiments with RsmF were performed with higher protein concen-
trations than those used in the RsmA assays because the affinity of RsmF for RsmY is 
10-fold lower than that of RsmA (Fig. 6A). In general, the RNA-binding activity of RsmF
was more sensitive to the GGA substitutions than that of RsmA. RsmFHis binding was 
detectable only for the GGA2 and GGA7 single mutants (Fig. 6B; Fig. S2B). None of the
remaining RsmY mutant probes bound to RsmFHis, even at high protein concentrations 
(Fig. 6; Fig. S2).
Effects of RsmZ GGA substitutions on RsmA and RsmF binding. RsmAHis binds 
RsmZ with a high affinity and forms three distinct complexes (Fig. 7A) (24). Disruption
of GGA site 1, 2, 5, or 6 had a significant effect on RsmAHis binding, with a 12- to 40-fold 
affinity reduction. Despite the reduction in affinity, RsmA binding to the GGA1, GGA2,
FIG 6 RsmA and RsmF binding to mutant RsmY RNAs. (A to F) The indicated RNAs were synthesized in vitro, radiolabeled, incubated with RsmA (lanes 1 to 5)
or RsmF (lanes 6 to 10), and analyzed by nondenaturing polyacrylamide gel electrophoresis. Complexes formed upon RsmA or RsmF binding to native RsmY
are indicated by arrows and numbered in panel A. Unbound RNA is indicated by an arrow in each panel.
GGA5, and GGA6 mutants still resulted in the formation of three distinct complexes (Fig. 
7B to E). In contrast, the GGA26, GGA15, and GGA56 double mutants demonstrated 
differences in complex formation, with the most affected mutant being GGA15, for 
which only one complex was detected (Fig. 7B and C). RsmA still bound mutant RsmZ 
probes lacking either three (sites 2, 5, and 6) or four (sites 1, 2, 5, and 6) of the GGA 
sequences presented in stem-loop structures (Fig. S3E and F). To determine if lower-
affinity interactions could account for binding to the RsmZ GGA1256 mutant, mutations 
were introduced at GGA sites 4 and 7. Although the RsmAHis affinity was not reduced 
for RsmZ GGA147 (Fig. S3G), disruption of GGA sites 1, 2, and 4 to 7 resulted in a
complete loss of RsmAHis binding (Fig. 7F).
Compared to that of RsmA, RsmF has a reduced affinity for wild-type RsmZ, and only 
1 or 2 shift products are formed (Fig. 7A). Whereas disruption of GGA site 2 or 6 resulted 
in a significant reduction in RsmFHis affinity (270 nM) (Fig. 7C and E), GGA substitu-
tions at sites 1 and 5 had no significant effect on affinity or complex formation (Fig. 7B
FIG 7 RsmA and RsmF binding to mutant RsmZ RNAs. (A to F) Labeled RNAs were incubated with RsmA (lanes 1 to 5) or RsmF (lanes 6 to 10) and analyzed
by nondenaturing polyacrylamide gel electrophoresis. Complexes formed upon RsmA or RsmF binding to native RsmZ are indicated by arrows and numbered
in panel A. Unbound RNA is indicated by an arrow in each panel.
and D). Consistent with the former finding, RsmF was unable to bind to the double 
mutants lacking GGA sites 2 and 6 or 5 and 6 (Fig. S3B and C), and binding was 
unaffected in the GGA15 mutant (Fig. S3D). The one anomalous finding was that the 
GGA25 mutant still supported RsmF binding (Fig. S3A), which contrasts with our finding 
that GGA site 2 is critical for binding (Fig. 7C). The addition of further GGA substitutions 
in RsmZ completely blocked RsmF binding (Fig. 7F; Fig. S3E to G).
The discrepancy between the in vivo and in vitro findings for RsmA likely reflects 
limitations of the in vitro binding assay. One possibility is that another RNA-binding 
protein interacts with RsmY and/or RsmZ and blocks RsmA binding at suboptimal GGA 
sites in vivo. One candidate protein is the RNA chaperone Hfq. Hfq binds to and 
stabilizes RsmY (38). We find that Hfq also binds to RsmZ, with an affinity in the low 
nanomolar range (Fig. S4A). To test whether Hfq prevents RsmA from binding to some 
GGA sites in vivo, wild-type RsmY or the RsmY GGA25 double mutant was expressed in 
wild-type PA103 or an hfq mutant. RsmA availability was measured using a previously 
described PexsD-lacZ transcriptional reporter (39). The PexsD-lacZ reporter measures type III
secretion gene expression and is dependent upon RsmA. Whereas overexpression of 
wild-type RsmY significantly reduced PexsD-lacZ reporter activity by sequestering RsmA, 
the RsmY GGA25 mutant lacked this activity in both the wild-type and Δhfq back-
grounds (Fig. S4B). Thus, even in the absence of Hfq, the RsmY GGA25 mutant was 
unable to effectively sequester RsmA.
DISCUSSION
The previous observation that RsmA and RsmF bind RsmY and RsmZ with different 
affinities led us to investigate the binding interactions with the RNAs. RsmY and RsmZ 
both have 7 GGA motifs within their sequence. Mfold predictions indicate that RsmY 
GGA sites 2, 5, and 7 are presented in the loop portion of stem-loop structures. 
Functional analyses of those sites identified roles for GGA sites 2 and 5 in the 
sequestration of both RsmA and RsmF. A role for GGA7 could not be demonstrated, 
consistent with SHAPE-MaP findings showing that GGA7 is base paired in a stem rather 
than being presented in a stem-loop structure. This conclusion is further supported 
by findings for the P. fluorescens RsmY homolog, wherein the sites analogous to P. 
aeruginosa GGA2 and GGA5 serve as the primary determinants for activity in vivo (35).
Mfold and SHAPE-MaP data for RsmZ are in agreement that GGA sites 2, 5, and 6 are 
presented in stem-loop structures. The NMR structure of P. fluorescens RsmZ also shows 
that the sites analogous to P. aeruginosa GGA sites 2, 5, and 6 are presented in the same 
manner. Functional assays, however, identified primary roles for GGA sites 1, 2, and 6 
in the sequestration of both RsmA and RsmF. A minor role for GGA site 5 was also 
evident in the GGA25 and GGA56 double mutants. The finding that in vivo activity 
requires GGA site 1 was unexpected, as the Mfold and SHAPE-MaP data indicated that 
site 1 is not presented in a stem-loop structure. We offer three potential interpretations 
of this observation. First, the GGA-to-CCU substitution in site 1 might significantly alter 
RsmY folding and render the RNA nonfunctional. Neither Mfold predictions for the site 
1 mutant nor qRT-PCR measurements of the RsmZ GGA1 half-life, however, suggest this 
to be the case. The second possibility is that RsmA/RsmF binding to site 1 is not 
dependent upon GGA being presented in a stem-loop structure. A similar situation has 
been demonstrated for several CsrA targets (40, 41). The final possibility is that the 
Mfold and SHAPE-MaP data are incorrect and that GGA site 1 is presented in a 
stem-loop structure. This seems unlikely, however, as the sequence surrounding site 1 
bears little resemblance to P. fluorescens GGA1 and the best potential stem is only 2 bp 
long, and likely unstable.
Assays using the tssA1 translational reporter defined clear roles for RsmY GGA sites 
2 and 5 and RsmZ GGA sites 1, 2, and 6 in the sequestration of RsmA/RsmF in vivo. RNA 
probes bearing the same substitutions, however, had only modest effects on RsmA 
binding activity in vitro. The discrepancy between the in vivo and in vitro findings likely 
reflects limitations of the in vitro binding assay. Interaction partners of RsmY and RsmZ 
are not limited to RsmA and RsmF. While our data suggest that Hfq does not account 
for the discrepancy, there are other proteins that interact with RsmY and RsmZ. 
Polynucleotide phosphorylase (PNPase), a protein involved in RNA processing and a 
component of the RNA degradosome, binds to and promotes RsmY and RsmZ turnover 
(42). A role for PNPase in differential processing of the mutant RNAs, however, is not 
supported by the qRT-PCR data, which show no significant differences in the half-lives 
of the mutant RNAs. The ability of RsmA to bind to RsmY GGA25 in vitro may also be 
due to differences under conditions (ion homeostasis) that contribute to RsmY’s ability 
to fold in vivo versus in vitro conditions.
Analyses of the mutant RsmY and RsmZ RNAs showed that RsmF has more stringent 
binding requirements than those of RsmA. As best illustrated in Table 1, RsmA dem-
onstrated high-affinity binding to 18 of the 21 RsmY and RsmZ mutant probes. In 
contrast, RsmF bound only 7 of the same probes, with significantly lower affinities. 
These findings are in agreement with the previous SELEX data (27) and further support 
the hypothesis that RsmF requires 2 or more optimal binding sites for high-affinity 
binding to target RNAs. It is unclear why RsmF binding activity is restricted in this





RsmY GGA2 2 13
RsmY GGA5 2 270
RsmY GGA7 0.2 99
RsmY GGA25 3 270
RsmY GGA57 2 270
RsmY GGA27 0.3 270
RsmY GGA134 0.5 270
RsmY GGA257 9 270
RsmY123457 9 270
RsmZ 0.1 84
RsmZ GGA1 0.2 79
RsmZ GGA2 2 270
RsmZ GGA5 1 34
RsmZ GGA6 4 270
RsmZ GGA25 0.1 16
RsmZ GGA56 4 270
RsmZ GGA26 0.2 270
RsmZ GGA15 0.6 63
RsmZ GGA147 0.1 270
RsmZ GGA256 0.4 270
RsmZ GGA1256 1 270
RsmZ GGA124567 3 270
manner or how that might affect the biology of the regulatory system. An answer to the 
latter question is complicated by the fact that a role for RsmY and RsmZ in the 
sequestration of RsmF has not been demonstrated under physiologically relevant 
conditions. The challenges lie in the fact that RsmA activity is dominant over that of 
RsmF, thus necessitating a requirement to remove RsmA from the system to assess 
RsmY/RsmZ effects on RsmF function, and that RsmYZ transcription is entirely RsmA 
dependent (i.e., in the absence of rsmA, no RsmY/RsmZ is produced). Experiments to 
date have therefore relied upon RsmY/RsmZ overexpression to demonstrate effects on 
RsmF function, but the results may be misleading. Another possibility is that biologi-
cally relevant targets, including primary sRNAs that sequester RsmF and mRNA targets 
subject to RsmF regulatory control, remain to be identified.
RsmA and RsmF are important global regulators contributing to the transition from 
the acute to the chronic infection phenotype. It remains to be determined if RsmY and 
RsmZ are the only sRNAs controlling RsmA and RsmF activity. RsmW, an sRNA upregu-
lated during biofilm growth, was recently found to bind RsmA (43), adding another
facet to RsmA regulation. Another factor to consider for the Rsm system is the temporal 
expression of RsmA and RsmF in comparison to that of the sRNAs, as observed in P. 
fluorescens. RsmX, RsmY, and RsmZ in P. fluorescens each have expression peaks at
different stages of growth (44). The different affinities of RsmA and RsmF for RsmY and
RsmZ may provide a mechanism for fine-tuning the expression of genes under the 
control of the Rsm system.
MATERIALS AND METHODS
Strain and plasmid construction. Routine cloning was performed with E. coli DH5 cultured in 
LB-Lennox medium with gentamicin (15 g/ml) as required. P. aeruginosa rsmA, rsmF, rsmAF, 
rsmYZ, and rsmAYZ mutants in the strain PA103 background were reported previously (see Table S1 
in the supplemental material) (24). The rsmFYZ mutant was constructed by introducing the previously 
described pEX18G2ΔrsmF allelic exchange vector (45) into the rsmYZ mutant. Merodiploids were 
resolved by sucrose counterselection as previously described (46). The RsmY expression plasmid was 
constructed by positioning the rsmY transcription start site immediately downstream of the PBAD 
promoter start site, using the Gibson assembly method (New England BioLabs). Briefly, the PBAD promoter 
region from pJN105 (primers 117830775 and 117830776) and rsmY (primers 118617707 and 118617708) 
were each amplified by PCR and then assembled into the MluI and SacI restriction sites of pJN105 (47). 
pRsmY and pRsmZ vectors bearing single GGA-to-CCT substitutions or various combinations thereof
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